M&A Deal Summary

Lunit Acquires Volpara Health

On December 14, 2023, Lunit acquired information technology company Volpara Health for 292M AUD

Acquisition Highlights
  • This is Lunit’s 1st transaction in the Information Technology sector.
  • This is Lunit’s largest (disclosed) transaction.
  • This is Lunit’s 1st transaction in New Zealand.

M&A Deal Summary

Date 2023-12-14
Target Volpara Health
Sector Information Technology
Buyer(s) Lunit
Deal Type Add-on Acquisition
Deal Value 292M AUD
Advisor(s) Minter Ellison (Legal)

Target

Volpara Health

Wellington, New Zealand
Volpara Health provides software to save families from cancer by helping healthcare providers positively impact communities around the world. The company is focused on understanding cancer risk, empowering patients in personal care decisions, improving and maintaining quality, and guiding recommendations about additional imaging, genetic testing, and other interventions. Its focus on customer value means that its AI-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality. Volpara Health is based in Wellington, New Zealand.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Lunit

Seoul, South Korea

Category Company
Founded 2013
Sector Information Technology
Revenue 25.1B KRW (2023)
DESCRIPTION

Lunit is a deep learning-based medical AI company committed to harnessing AI to ensure accurate diagnosis and optimal treatment for each cancer patient using AI-powered medical image analytics and AI biomarkers. As a medical AI company grounded on clinical evidence, the company's findings are presented in major peer-reviewed journals, such as the Journal of Clinical Oncology and the Lancet Digital Health, and global conferences, including ASCO and RSNA. After receiving FDA clearance and the CE Mark, its flagship Lunit INSIGHT suite is clinically used in approximately 3,000+ hospitals and medical institutions across 40+ countries. Lunit was founded in 2013 and is based in Seoul, South Korea.


DEAL STATS #
Overall 1 of 1
Sector (Information Technology) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (New Zealand) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 1